Literature DB >> 33585502

Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses.

Marni E Cueno1, Kenichi Imai1.   

Abstract

Coronaviruses (CoV) are enveloped positive-stranded RNA viruses and, historically, there are seven known human-infecting CoVs with varying degrees of virulence. CoV attachment to the host is the first step of viral pathogenesis and mainly relies on the spike glycoprotein located on the viral surface. Among the human-infecting CoVs, only the infection of SARS CoV 2 (SARS2) among humans resulted to a pandemic which would suggest that the protein structural conformation of SARS2 spike protein is distinct as compared to other human-infecting CoVs. Surprisingly, the possible differences and similarities in the protein structural conformation between the various human-infecting CoV spike proteins have not been fully elucidated. In this study, we utilized a computational approach to generate models and analyze the seven human-infecting CoV spike proteins, namely: HCoV 229E, HCoV OC43, HCoV NL63, HCoV HKU1, SARS CoV, MERS CoV, and SARS2. Model quality assessment of all CoV models generated, structural superimposition of the whole protein model and selected S1 domains (S1-CTD and S1-NTD), and structural comparison based on RMSD values, Tm scores, and contact mapping were all performed. We found that the structural orientation of S1-CTD is a potential structural feature associated to both the CoV phylogenetic cluster and lineage. Moreover, we observed that spike models in the same phylogenetic cluster or lineage could potentially have similar protein structure. Additionally, we established that there are potentially three distinct S1-CTD orientation (Pattern I, Pattern II, Pattern III) among the human-infecting CoVs. Furthermore, we postulate that human-infecting CoVs in the same phylogenetic cluster may have similar S1-CTD and S1-NTD structural orientation. Taken together, we propose that the SARS2 spike S1-CTD follows a Pattern III orientation which has a higher degree of similarity with SARS1 and some degree of similarity with both OC43 and HKU1 which coincidentally are in the same phylogenetic cluster and lineage, whereas, the SARS2 spike S1-NTD has some degree of similarity among human-infecting CoVs that are either in the same phylogenetic cluster or lineage.
Copyright © 2021 Cueno and Imai.

Entities:  

Keywords:  C-terminal domain (CTD); N-terminal domain (NTD); SARS coronavirus 2 (SARS2); modeling; spike

Year:  2021        PMID: 33585502      PMCID: PMC7874069          DOI: 10.3389/fmed.2020.594439

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  60 in total

1.  Immunological speculations.

Authors:  N K JERNE
Journal:  Annu Rev Microbiol       Date:  1960       Impact factor: 15.500

Review 2.  Human Coronavirus: Host-Pathogen Interaction.

Authors:  To Sing Fung; Ding Xiang Liu
Journal:  Annu Rev Microbiol       Date:  2019-06-21       Impact factor: 15.500

3.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  CMView: interactive contact map visualization and analysis.

Authors:  Corinna Vehlow; Henning Stehr; Matthias Winkelmann; José M Duarte; Lars Petzold; Juliane Dinse; Michael Lappe
Journal:  Bioinformatics       Date:  2011-04-05       Impact factor: 6.937

Review 5.  Mapping the protein universe.

Authors:  L Holm; C Sander
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

6.  Methods of protein structure comparison.

Authors:  Irina Kufareva; Ruben Abagyan
Journal:  Methods Mol Biol       Date:  2012

Review 7.  Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis.

Authors:  Jean Kaoru Millet; Gary R Whittaker
Journal:  Virus Res       Date:  2014-11-22       Impact factor: 3.303

8.  Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.

Authors:  Xiao-Yan Che; Li-Wen Qiu; Zhi-Yong Liao; Ya-di Wang; Kun Wen; Yu-Xian Pan; Wei Hao; Ya-Bo Mei; Vincent C C Cheng; Kwok-Yung Yuen
Journal:  J Infect Dis       Date:  2005-05-06       Impact factor: 5.226

9.  Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.

Authors:  Huibin Lv; Nicholas C Wu; Owen Tak-Yin Tsang; Meng Yuan; Ranawaka A P M Perera; Wai Shing Leung; Ray T Y So; Jacky Man Chun Chan; Garrick K Yip; Thomas Shiu Hong Chik; Yiquan Wang; Chris Yau Chung Choi; Yihan Lin; Wilson W Ng; Jincun Zhao; Leo L M Poon; J S Malik Peiris; Ian A Wilson; Chris K P Mok
Journal:  Cell Rep       Date:  2020-05-18       Impact factor: 9.423

10.  Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests.

Authors:  Kwok-Hung Chan; Jasper Fuk-Woo Chan; Herman Tse; Honglin Chen; Candy Choi-Yi Lau; Jian-Piao Cai; Alan Ka-Lun Tsang; Xincai Xiao; Kelvin Kai-Wang To; Susanna Kar-Pui Lau; Patrick Chiu-Yat Woo; Bo-Jiang Zheng; Ming Wang; Kwok-Yung Yuen
Journal:  J Infect       Date:  2013-04-10       Impact factor: 6.072

View more
  17 in total

1.  Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.

Authors:  David J Gregory; Augustin Vannier; Akiro H Duey; Tyler J Roady; Richard K Dzeng; Maia N Pavlovic; Michael H Chapin; Sonia Mukherjee; Hannah Wilmot; Nic Chronos; Richelle C Charles; Edward T Ryan; Regina C LaRocque; Tyler E Miller; Wilfredo F Garcia-Beltran; Julia C Thierauf; A John Iafrate; Steven Mullenbrock; Mark D Stump; Randall K Wetzel; Roberto D Polakiewicz; Vivek Naranbhai; Mark C Poznansky
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

2.  Potential Use of Tea Tree Oil as a Disinfectant Agent against Coronaviruses: A Combined Experimental and Simulation Study.

Authors:  Alice Romeo; Federico Iacovelli; Carolina Scagnolari; Mirko Scordio; Federica Frasca; Roberta Condò; Serena Ammendola; Roberta Gaziano; Maurizio Anselmi; Maurizio Divizia; Mattia Falconi
Journal:  Molecules       Date:  2022-06-12       Impact factor: 4.927

Review 3.  Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV.

Authors:  Disha Panchal; Jeena Kataria; Kamiya Patel; Kaytlyn Crowe; Varun Pai; Abdul-Rahman Azizogli; Neil Kadian; Sreya Sanyal; Abhishek Roy; Joseph Dodd-O; Amanda M Acevedo-Jake; Vivek A Kumar
Journal:  Adv Ther (Weinh)       Date:  2021-08-06

4.  Antiviral Activity of Contemporary Contact Lens Care Solutions against Two Human Seasonal Coronavirus Strains.

Authors:  Christiane Lourenco Nogueira; Scott Joseph Boegel; Manish Shukla; William Ngo; Lyndon Jones; Marc G Aucoin
Journal:  Pathogens       Date:  2022-04-15

Review 5.  Marine mollusc extracts-Potential source of SARS-CoV-2 antivirals.

Authors:  Rebecca L Pedler; Peter G Speck
Journal:  Rev Med Virol       Date:  2021-11-02       Impact factor: 11.043

6.  IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.

Authors:  Jiong Wang; Dongmei Li; Andrew Cameron; Qian Zhou; Alexander Wiltse; Jennifer Nayak; Nicole D Pecora; Martin S Zand
Journal:  J Infect Dis       Date:  2022-08-26       Impact factor: 7.759

7.  Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals.

Authors:  A Karim Embong; Phuong Nguyen-Contant; Jiong Wang; Preshetha Kanagaiah; Francisco A Chaves; Theresa F Fitzgerald; Qian Zhou; Gabrielle Kosoy; Angela R Branche; Benjamin L Miller; Martin S Zand; Mark Y Sangster; David J Topham
Journal:  Pathogens       Date:  2022-01-29

8.  Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors.

Authors:  Valery A Petrenko; James W Gillespie; Laura Maria De Plano; Michael A Shokhen
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

9.  Potentiometric Biosensors Based on Molecular-Imprinted Self-Assembled Monolayer Films for Rapid Detection of Influenza A Virus and SARS-CoV-2 Spike Protein.

Authors:  Won-Il Lee; Ashwanth Subramanian; Steffen Mueller; Kalle Levon; Chang-Yong Nam; Miriam H Rafailovich
Journal:  ACS Appl Nano Mater       Date:  2022-04-12

Review 10.  Beneficial Properties of Bromelain.

Authors:  Pawel Hikisz; Joanna Bernasinska-Slomczewska
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.